LeMaitre Vascular (LMAT) Competitors

Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both mid-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Is STVN or LMAT more profitable?

LeMaitre Vascular has a net margin of 20.08% compared to Stevanato Group's net margin of 11.73%. LeMaitre Vascular's return on equity of 13.67% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.73%	10.34%	6.21%
LeMaitre Vascular	20.08%	13.67%	9.14%

Which has higher earnings & valuation, STVN or LMAT?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.19B	6.95	€127.45M	€0.54	50.78
LeMaitre Vascular	$219.86M	9.52	$44.04M	$2.06	44.88

Do insiders & institutionals have more ownership in STVN or LMAT?

84.6% of LeMaitre Vascular shares are held by institutional investors. 9.5% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Is STVN or LMAT a better dividend stock?

Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.2%. LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 0.9%. Stevanato Group pays out 11.1% of its earnings in the form of a dividend. LeMaitre Vascular pays out 38.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stevanato Group has raised its dividend for 1 consecutive years and LeMaitre Vascular has raised its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do analysts rate STVN or LMAT?

LeMaitre Vascular has a consensus price target of $97.60, indicating a potential upside of 5.57%. Given LeMaitre Vascular's higher possible upside, analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.83
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Does the media prefer STVN or LMAT?

In the previous week, LeMaitre Vascular had 1 more articles in the media than Stevanato Group. MarketBeat recorded 8 mentions for LeMaitre Vascular and 7 mentions for Stevanato Group. LeMaitre Vascular's average media sentiment score of 1.12 beat Stevanato Group's score of 1.08 indicating that LeMaitre Vascular is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, STVN or LMAT?

Stevanato Group has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Summary

LeMaitre Vascular beats Stevanato Group on 13 of the 20 factors compared between the two stocks.